With the announcement of 'Consistency Evaluation of Quality and Efficacy of Generic Drugs', 'Adjusting the Evaluation and Approval of API, Excipients and Packaging Materials' and related reviews and approvals issued consecutively in China, pharmaceutical enterprises have now the responsibility for the selection of pharmaceutical excipients. Driven by the policy, tremendous challenges and opportunities have burgeoned and key innovations have been fostered in new products, new dosage forms and new technologies among pharmaceutical excipients and packages.
PharmaExcipients China 2020 will be launched at Hall E3 of Shanghai New International Expo Centre from December 16 to 18, 2020. During the 3-day exhibition, high-quality enterprises of pharmaceutical excipients at home and abroad will gather to showcase the innovations in the excipient industry. Authoritative industry leaders and experienced experts will attend to interpret the latest excipients policies and forecast the market trends, helping the pharma excipients companies break through the threshold of R&D technology and accelerate the integration into the international standards system.
The digital extension of the physical CPhI & P-MEC China event, "Virtual Expo Connect", will be launched from November 18th for 31 days. The hybrid "Virtual Expo Connect" offers an online alternative for international visitors unable to travel to the physical show in China due to travel restrictions, adding valued services and infinite opportunities to connect, learn, trade and grow.